Robust therapeutic effects on COVID-19 of novel small molecules: Alleviation of SARS-CoV-2 S protein induction of ACE2/TMPRSS2, NOX2/ROS, and MCP-1

By sjmartinez • October 4, 2022

Youn JY, Wang J, Li Q, Huang K, Cai H. Robust therapeutic effects on COVID-19 of novel small molecules: Alleviation of SARS-CoV-2 S protein induction of ACE2/TMPRSS2, NOX2/ROS, and MCP-1. Front Cardiovasc Med. 2022 Sep 15;9:957340. doi: 10.3389/fcvm.2022.957340. PMID: 36187008; PMCID: PMC9520320.

Tags: acute respiratory distress syndrome (ARDS), Cardiology/Epi, covid-19, endothelial dysfunction, NADPH oxidase isoform 2 (NOX2), Publications, SARS-CoV-2

Pulsed Field Ablation as Initial Therapy for Persistent Atrial Fibrillation

Wazni OM, Chun KRJ, Nair DG, Anic A, Duytschaever M, Chrispin J, Amin A, Ajijola OA, Gibson DN, Mansour M, Piccini JP, Natale A, Badin[...]

Coronary computed tomography angiography versus functional testing in a multi-ethnic urban county population

Colasurdo JR, Yamamoto N, Kinninger A, Budoff MJ, Roy SK. Coronary computed tomography angiography versus functional testing in a multi-ethnic urban county population. Coron Artery[...]

Characteristics and Outcomes of Over One Million Veterans with Heart Failure Phenotyped Using Artificial Intelligence Approaches: The National DCVA-HF Registry

Zhang S, Raman VK, Shao Y, Patel S, Cheng Y, Workman TE, Sheriff HM, Fonarow GC, Lam PH, Heidenreich PA, Morgan CJ, Moore HJ, Vargas[...]